HOME >> BIOLOGY >> NEWS
Dietary soy reduces pain, inflammation in rats

A diet rich in soy appears to decrease inflammation-induced pain in rats, according to a study by Johns Hopkins researchers.

The research, to be presented March 15 at the annual meeting of the American Pain Society in Baltimore, shows that rats with chronic pain resulting from inflammation similar to the pain experienced by some cancer patients were more tolerant of painful heat stimuli and had less swelling of the inflamed region when fed a diet based on soy protein.

More than two-thirds of patients with advanced cancer suffer from chronic pain. Managing this is a complex issue for physicians, who struggle to find both the nature of the pain and the most effective treatments. The causes can be a combination of pain resulting from tissue infiltration and inflammation, and neuropathic pain from tumors creeping into a nerve bed. Additionally, when cancer cells spread to bone, they may release chemicals that trigger a painful response. The most effective medications to date have been opioids such as morphine, but the side effects like constipation are so severe that not all patients can tolerate them.

"Our generation is very open to the idea of dietary methods of pain control," says Jill M. Tall, Ph.D., lead author of the study and a research fellow at Hopkins. "We hope to find complementary and alternative treatments to help people suffering from pain."

Researchers studied two groups of 10 rats. For two weeks, the first group consumed a diet based on casein protein (a milk protein found in cheese) while the second group ate a soy protein diet. At random, researchers injected either a placebo or a solution designed to induce inflammatory pain to one of the rats' hind paws.

Paw thickness was measured to assess fluid build-up. Pain tolerance was measured by assessing how long the rats could tolerate a painful heat stimulus before withdrawing the inflamed paw, and how they reacted to varying pressures applied to t
'"/>

Contact: Karen Blum
kblum@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
15-Mar-2002


Page: 1 2

Related biology news :

1. Dietary supplement shows promise for improving immune function in the elderly
2. Dietary supplement many not lower prostate cancer risk
3. Dietary ginger may work against cancer growth
4. Dietary component kills bacterial cause of ulcers and stomach cancer
5. Dietary changes can lower colon cancer risk in families with a history of the disease
6. Dietary supplements make old rats youthful, may help rejuvenate aging humans, according to UC Berkeley study
7. Dietary approaches to stop hypertension diet reduces cholesterol and long-term cardiovascular risk
8. Dietary study finds marijuana users have normal nutritional status, risky lifestyle habits
9. Dietary fibre supplements may be harmful
10. Dietary fat itself not likely to cause breast cancer
11. Dietary patterns predict heart attack risk in middle-aged men

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Dietary soy reduces pain inflammation rats

(Date:5/23/2013)... the new mechanism by which estrogen suppresses lipid synthesis ... potential new approach toward treating certain liver diseases. ... believe they are changing long-held views in the field. ... the journal Science Signaling . , "The dogma ... been that only receptors located in the nucleus respond ...
(Date:5/23/2013)... A new report from the Institute of Medicine ... in at least 60 minutes of vigorous or moderate ... than half of American youth meet current evidence-based guidelines ... intensity physical activity daily, according to the report, which ... school for nearly half of their waking hours, the ...
(Date:5/23/2013)... , the team reveal the interplay of brain chemicals ... the Wellcome Trust and BBSRC. , By changing ... our perceptual abilities. While these changes can affect the ... the fidelity of that response. , Lead ... you communicate with others, you can make yourself better ...
Breaking Biology News(10 mins):UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Schools should provide students with daily physical activity, IOM recommends 2
(Date:5/23/2013)... 23, 2013 PuraMed BioScience ® , ... of over-the-counter (OTC) medicinal and healthcare products, announced ... the company based on low market capitalization valuation. ... All Natural Product to Treat Migraine Headaches ... Prescription Competitor , Currently Available Nationwide at ...
(Date:5/23/2013)... HILLS, Calif. , May 23, 2013  Saddleback ... recently became the first hospital on the ... robotic technology. This new surgical option provides women with ... Marc Winter , M.D., ... gynecologist and surgeon and medical director of minimally invasive ...
(Date:5/23/2013)... 2013 Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced ... year,s American Society Of Clinical Oncology (ASCO) meeting in ... role in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ... the pre-eminent conference focused on clinical treatment of cancer, ...
(Date:5/23/2013)... 23, 2013 Pusan National University Yangsan ... biotherapeutics and contract research company focused on research ... announced today a publication reporting the induction of ... oncolytic and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; Jennerex ... in the May 15 th , 2013 issue ...
Breaking Biology Technology:PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3
Cached News: